Synopsis Lacidipine is an orally administered calcium channel blocker of the
dihydropyridine class, which shows selectivity for vascular smooth muscle over cardiac …

The present study was aimed at evaluating the antihypertensive efficacy of sustained-
release diltiazem 180 mg vs. sustained-release nicardipine 40 mg both given twice daily. To …

The new slow-release oral formulation (SRO) of isradipine, a dihydropyridine calcium
antagonist, was evaluated in 57 patients who had moderate-tosevere hypertension following …

Ambulatory blood pressure monitoring (ABPM) is a particularly useful method for evaluating
the effects of antihypertensive drugs. ABPM allows the therapeutic effect of an agent to be …

1. The objective of this double‐blind parallel‐group study was to compare the tolerability of
isradipine and amlodipine, specifically, the side‐effects known to be related to the use of …

Six hundred outpatients aged between 22 and 84 years with essential hypertension
(diastolic blood pressure of at least 95 mm Hg) entered a multinational, multicenter, single …

Thirty patients (17 females, median age 55 years) with mild/moderate hypertension (sitting
diastolic blood pressure 95-110 mmHg over 2 consecutive weeks) participated in a study of …

The clinical efficacy and tolerability of isradipine was evaluated in 63 patients with mild-to-
moderate hypertension [supine systolic blood pressure (SBP)>= 160 mm Hg and diastolic …

At the end of a short-term (3-month) study of antihypertensive treatment of mild-to-moderate
hypertension, 141 of the 200 study patients continued into a 2-year follow-up of isradipine as …

This randomized, double-blind, placebo-controlled, parallel-group study evaluated the
efficacy and safety of single daily dose diltiazem extended-release (XR) and indapamide …